Translational development of splice-modifying antisense oligomers.
about
Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues.Rational Design of Short Locked Nucleic Acid-Modified 2′-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro.The contribution of alternative splicing to genetic risk for psychiatric disorders.
P2860
Translational development of splice-modifying antisense oligomers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Translational development of splice-modifying antisense oligomers.
@en
type
label
Translational development of splice-modifying antisense oligomers.
@en
prefLabel
Translational development of splice-modifying antisense oligomers.
@en
P2093
P2860
P1476
Translational development of splice-modifying antisense oligomers.
@en
P2093
A P Akkari
M I Bellgard
S D Wilton
P2860
P356
10.1080/14712598.2017.1250880
P407
P50
P577
2016-11-02T00:00:00Z